IVF - ASSESSMENT OF THE REPRODUCTIVE ENVIROMENT
E-ready is the test that allows differentiation of the ovarian cycle by identifying the correct timing of the implantation window, thus providing clinicians with an additional tool to prevent cycle failure during fertility treatments.
The results obtained from the E-ready test can provide the physician with valuable information regarding the timing of embryo transfer obtained through assisted reproductive technologies or guide targeted therapeutic interventions.
The aim is to reduce the risk of implantation failure and increase the chances of pregnancy.
E-READY
Available panels
E-Ready
E-READY
Who it's recommended for
The test is aimed at:
Women who have undergone unsuccessful ART cycles (even with confirmed euploid embryos)
Women with a thin endometrium
Women undergoing their first IVF cycle to maximize the chances of success
E-READY
Analysis method
The E-ready test is a personalized medicine test aimed at providing doctors with information about endometrial receptivity through the analysis of the expression of 68 genes on an endometrial biopsy.
The gene expression profile is assessed using TACseq technology from Illumina Inc., which is based on sequencing through Next Generation Sequencing (NGS) followed by data analysis using dedicated software.
Scientific publications in support
(1) Simon et al., Reprod Biomed Online. 2020 Sep;41(3):402-415.
(2) Haouzzi et al., Reprod Sci. 2021 Jan;28(1):69-78.
(3) Fertil Steril. 2013 Feb;99(2):508-17.
IVF - ASSESSMENT OF THE REPRODUCTIVE ENVIROMENT